Komori
Rix (7525) · InitiativeAdvanced

Strengthening Wastewater Treatment Facilities and Developing the Pharmaceutical and Cosmetics Industries

First written in FY2022-Q1. 10 of 14 entries say "Advanced", first in FY2023-Q1. Latest entry: FY2026.

14entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseReframedFY2022-Q2AdvancedFY2023 – FY20262021: 220212022: 220222023: 420232024: 320242025: 220252026: 12026
Same theme, other companies
Revenue and profit growth in the environmental equipment businessA theme 11 companies write about · 1 as a headwind · 16 as a tailwind

The whole theme swung hardest in 2022: 2 of 8 companies on the "Worse" side.

7 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「The Group focused on developing the pharmaceutical and cosmetics fields, as well as the repair and refurbishment business. Although sales of equipment for capacity-expansion investments by advanced-materials manufacturers and equipment for production lines performed well, they were insufficient to offset the decline from the prior fiscal year, resulting in lower revenue.」

    In addition to developing the pharmaceutical and cosmetics fields and the repair and refurbishment business, the company has expanded into equipment sales for capacity expansion and production lines at advanced-materials manufacturers.
  2. FY2026-H1AdvancedAnnual report

    「The Group focused on developing the pharmaceutical and cosmetics fields and deepening engagement with existing customers. Although cooling-equipment rental projects for chemical manufacturers and sales of the Group's original blowers to government agencies performed well, sales declined because a large project recorded in the prior-year period was absent this fiscal year.」

    Development of the pharmaceutical and cosmetics fields and deeper engagement with existing customers have expanded into cooling-equipment rental projects and sales of proprietary blowers to government agencies.
  3. FY2025AdvancedAnnual report

    「At the Group, efforts to develop the pharmaceutical and cosmetics fields and deepen relationships with existing customers resulted in higher revenue through exhaust-gas treatment equipment projects for newly built factories and the specification of rotating machinery for resin product manufacturing processes, among other factors.」

    Development of the pharmaceutical and cosmetics fields and deeper engagement with existing customers have taken concrete form in projects for exhaust-gas treatment equipment for new plants and rotary machinery for resin-product manufacturing processes.
  4. FY2025-H1AdvancedAnnual report

    「At the Group, efforts to develop the pharmaceutical and cosmetics fields and focus on repair and refurbishment businesses resulted in higher revenue from continuing rental projects related to equipment failures, sales of pumps for maintenance departments and equipment refurbishment projects, among other factors.」

    In addition to developing the pharmaceutical and cosmetics fields, the company has expanded its initiatives to rentals for responding to equipment problems, pumps for maintenance operations and equipment refurbishment projects.
  5. FY2024AdvancedAnnual report

    「At the Group, efforts to focus on repair and refurbishment businesses and develop the pharmaceutical and cosmetics fields resulted in higher revenue, supported by strong sales of seals, sales of large resin blowers and sales of components to medical equipment manufacturers, among other factors.」

    Development of the pharmaceutical and cosmetics fields and the repair and refurbishment business continued, expanding into sales of medical equipment-related components and large resin blowers.
  6. FY2024-Q3AdvancedAnnual report

    「The Group focused on developing the pharmaceutical and cosmetics fields, as well as the repair and refurbishment business. As a result, sales increased through orders for rental products needed due to equipment problems and sales of filters to equipment manufacturers, but remained below the prior-year period.」

    In addition to developing the pharmaceutical and cosmetics fields, the company has expanded its initiatives to rental products for responding to equipment problems and filter sales to equipment manufacturers through its repair and refurbishment business.
  7. FY2024-Q2AdvancedAnnual report

    「In addition to developing the pharmaceutical and cosmetics fields, the company focused on its repair and refurbishment business. Although it received orders for projects involving transfer equipment for raw-material processes and had other positive factors, overall results fell short of the previous year's corresponding period.」

    The company has continued developing the pharmaceutical and cosmetics fields and its repair and refurbishment business, leading to orders for transfer equipment projects for raw-material processes.
  8. FY2024-Q1AdvancedAnnual report

    「At the Group, efforts to develop the pharmaceutical and cosmetics fields and focus on repair and refurbishment businesses resulted in increased orders related to filters. However, the Group was affected by the absence of equipment renewal projects that had been recorded in the same period of the previous year, among other factors.」

    The company is advancing development of the pharmaceutical and cosmetics fields and its repair and refurbishment business, driving growth in orders related to filters.
  9. FY2023AdvancedAnnual report

    「The Group focused on developing the advanced film industry and the pharmaceutical and cosmetics fields. As a result, sales increased through orders for new tanks for supplying raw materials and associated pumps.」

    Development of the pharmaceutical and cosmetics fields and deeper engagement with high-performance film manufacturers led to orders for new tank installation projects and pumps.
  10. FY2023-Q3RestatedAnnual report

    「At the Group, efforts to develop the pharmaceutical and cosmetics fields and focus on filter sales resulted in higher revenue, supported by strong sales of filters and seals and projects to modify existing equipment, among other factors.」

    The company has continued focusing on developing the pharmaceutical and cosmetics fields and selling filters, with higher sales reported from filters, seals and modification projects for existing equipment.
  11. FY2023-Q2RestatedAnnual report

    「At the Group, efforts to develop the pharmaceutical and cosmetics fields and focus on filter sales resulted in higher revenue from sales of NF membrane units and repair projects for vacuum pumps, among other items.」

    The company has continued developing the pharmaceutical and cosmetics fields and expanded its initiatives to filter sales, NF membrane units and vacuum pump repair projects.
  12. FY2023-Q1AdvancedAnnual report

    「The Group focused on developing the pharmaceutical and cosmetics fields, as well as the repair and refurbishment business. As a result, increased sales of air cleaners and cleaning equipment, along with construction projects for cold isostatic pressing equipment, contributed to higher revenue.」

    In addition to developing the pharmaceutical and cosmetics fields, the company is advancing its repair and refurbishment business, driving higher sales from related equipment sales and construction projects.
  13. FY2022-Q2ReframedAnnual report

    「The Group worked to deepen engagement with advanced film manufacturers and focused on developing the pharmaceutical and cosmetics industries. As a result, sales of equipment for pharmaceutical materials companies and dust collectors for insulating-material manufacturers increased.」

    The focus of the disclosures has changed from activities for wastewater treatment equipment in the previous period to deeper engagement with high-performance film manufacturers, equipment for pharmaceutical-materials companies, and dust collectors for thermal insulation-material manufacturers.
  14. FY2022-Q1First statedAnnual report

    「As a result of strengthening activities for wastewater treatment equipment and focusing on developing the pharmaceutical and cosmetics industries, sales increased for vacuum pumps for plants and permanent-magnet grinding machines.」

    In the advanced materials industry, the company strengthened activities for wastewater treatment equipment and developed the pharmaceutical and cosmetics industries, driving sales growth for vacuum pumps and permanent-magnet grinding machines.
Moved together

"Entry into and expansion in the secondary battery and motor sectors" moved the same way as this thread, in the same document, in 10 of its 14 moves.

1099987★123456
  1. ★This thread
  2. 1Entry into and expansion in the secondary battery and motor sectors10×
  3. 2Expansion of Sales Activities to the Maintenance and Operations Divisions9×
  4. 3Capital investment in production and R&D facilities9×
  5. 4Strengthening Initiatives in the Energy Sector9×
  6. 5Exploring Growth Areas Including Vehicle Electrification and Renewable Energy8×
  7. 6Year-on-Year Declines in Revenue and Profit7×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Rix yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Strengthening Wastewater Treatment Facilities and Developing the Pharmaceutical and Cosmetics Industries | RIX CORPORATION (7525) | Komori